Testing effectiveness (Phase 2)WithdrawnNCT05702788
What this trial is testing
Efficacy and Safety of Jaktinib in Participants With Severe Novel Coronavirus Pneumonia(COVID-19)
Who this might be right for
COVID-19Pneumonia
Suzhou Zelgen Biopharmaceuticals Co.,Ltd